NSETrading Window2d ago · 28 Oct 2026, 04:35 pm

Trading Window

Paras Healthcare Limited · PARASHLTH

✦ AI SummaryRegulatory

Paras Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015. The Trading Window will be closed from October 28, 2026, till forty-eight hours after the declaration of Unaudited Standalone and Consolidated Financial Results for the quarter and half year ended September 30, 2026.

Analysis Scores

Earnings Impact5/10
Growth Catalyst3/10
Governance Concern2/10
Regulatory Risk8/10
Balance Sheet Risk4/10
Liquidity Impact6/10
Market Sentiment5/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Paras Healthcare Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations, 2015

Attachments (1)

📄

PARASHEALTH_28102026163517_Trading_Window_closure_October_28_2026.pdf

pdf

Download →
View document text
Date: October 28, 2026 To, To, National Stock Exchange of India Limited, BSE Limited, Exchange Plaza, C-1, Block G, Phiroze Jeejeebhoy Towers, Bandra Kurla Complex, Dalal Street, Mumbai – 400001 Bandra (E), Mumbai – 400051 BSE Scrip Code: 545005 NSE Scrip Symbol: PARASHLTH Subject: Closure of Trading Window under Securities and Exchange Board of India (Prohibition of Insider Trading) Regulations, 2015 (“SEBI PIT Regulations”) Dear Sir/Madam, This is to inform you that pursuant to the provisions of the SEBI PIT Regulations and the Company’s Code of Conduct for Prohibition of Insider Trading, the Trading Window for dealing in Company’s securities shall be closed from Wednesday, October 28, 2026, till forty-eight (48) hours after the declaration of Unaudited Standalone and Consolidated Financial Results (“Financial Results”) of the Company for the quarter and half year ended September 30, 2026. Accordingly, all the Designated Persons of the Company and their immediate relatives shall be strictly prohibited to deal in the securities of the Company during the aforesaid period. Date of the Meeting of the Board of Directors, proposed to be held, inter-alia, to consider and approve the aforesaid Financial Results will be intimated in due course. This disclosure will also be hosted on the Company’s website at https://www.parashospitals.com/investors. We request you to kindly take the above information on record. Thanking you. For Paras Healthcare Limited Rahul Kumar Company Secretary and Compliance Officer ICSI Membership No.: A20928